IL2 and neoplasm: Therefore, in the lung metastasis model, Lipo-αCD137/IL-2-Fc therapy could eradicate tumors in a fraction of animals when therapy was administered at an early stage and also significantly inhibited tumor growth in the lungs even the therapy was initiated at later stages of tumor progression.